Who Owns CLYM?

Climb Bio, Inc. — Institutional Ownership & 13F Holdings

$9.49

+0.41 (+4.43%)

Market Cap

$623.2M

Shares Outstanding

68,184,432

Institutional Holders

75

Total Inst. Value

$25.1M

% of Float Held

86.8%

QoQ Holder Change

+54

Institutional data as of Q1 2025

New Positions

13

Closed Positions

16

Increased

23

Decreased

22

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BlackRock, Inc.$2.8M2,296,424
2CANTOR FITZGERALD, L. P.$2.4M1,999,415
3CITIGROUP INC$2.3M1,850,118
4VANGUARD GROUP INC$1.8M1,502,556
5Affinity Asset Advisors, LLC$1.8M1,500,000
6Kynam Capital Management, LP$1.3M1,047,000
7Deep Track Capital, LP$1.3M1,040,115
8TANG CAPITAL MANAGEMENT LLCNew$1.2M1,000,000
9GEODE CAPITAL MANAGEMENT, LLC$821K673,811
10DIADEMA PARTNERS LP$817K669,803

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold CLYM?

As of Q1 2025, 75 institutional investors report holding CLYM (Climb Bio, Inc.) in their 13F filings.

What percentage of Climb Bio, Inc. is owned by institutions?

Institutional investors hold approximately 86.8% of Climb Bio, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most CLYM?

The largest institutional holder of CLYM is BlackRock, Inc. with $2.8M in shares.

Are institutions buying or selling CLYM?

This quarter, 13 institutions opened new positions in CLYM and 16 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.